Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation

•Busulfan exposure is associated with OS; 5-year survival with an exposure of ≥59.5 vs

Saved in:
Bibliographic Details
Published in:Blood advances 2023-09, Vol.7 (18), p.5225-5233
Main Authors: Tamari, Roni, Scordo, Michael, Kunvarjee, Binni M., Proli, Anthony, Lin, Andrew, Flynn, Jessica, Cho, Christina, Devlin, Sean, Klein, Elizabeth, Boulad, Farid, Cancio, Maria I., Curran, Kevin J., Jakubowski, Ann A., Kernan, Nancy A., Kung, Andrew L., O’Reilly, Richard J., Papadopoulos, Esperanza B., Prockop, Susan, Scaradavou, Andromachi, Shaffer, Brian C., Shah, Gunjan, Spitzer, Barbara, Gyurkocza, Boglarka, Giralt, Sergio A., Perales, Miguel-Angel, Boelens, Jaap Jan
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Busulfan - adverse effects
Child
Child, Preschool
Hematopoiesis and Stem Cells
Hematopoietic Stem Cell Transplantation - adverse effects
Humans
Middle Aged
Retrospective Studies
Transplantation Conditioning - adverse effects
Transplantation, Homologous
Young Adult
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Busulfan exposure is associated with OS; 5-year survival with an exposure of ≥59.5 vs
ISSN:2473-9529
2473-9537
2473-9537
DOI:10.1182/bloodadvances.2023009708